ABT-491 hydrochloride, >=98% (HPLC)
Biochem/physiol Actions
Highly potent, selective and orally active platelet-activating factor (PAF) receptor antagonist. Ki = 0.6 nM in human platelets.
Features and Benefits
This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is featured on the PAF Receptor page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Packaging
5, 25 mg in glass bottle
| Colour | white to beige |
|---|---|
| Quality Level | 100 |
| mp | 170-178 °C (lit.) |
| InChI key | AWRGBOKANQBIBM-UHFFFAOYSA-N |
| InChI | 1S/C28H22FN5O2.ClH/c1-5-18-7-6-8-25-26(18)21(16-34(25)28(36)32(3)4)27(35)19-9-10-20(22(29)13-19)15-33-17(2)31-23-14-30-12-11-24(23)33;/h1,6-14,16H,15H2,2-4H3;1 |
| Manufacturer | SIGMA-ALDRICH |
| Form | solid |
| Assay | ≥98% (HPLC) |
There are no downloads for this product.
